CLINICAL_TRIALS
trial_result
· 2026-07-20
Clinical Trial Results: A Study of Once-Daily Oral Orforglipron (LY3502970) in Japanese Adult Participants With Obesity Disease [Phase 3]
Summary
Phase 3 trial results for once-daily oral orforglipron (LY3502970) in Japanese adults with obesity have been completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Obesity | Phase 3 | Status: COMPLETED | Results posted: 2026-07-20